Andreessen Horowitz (a16z)Investing Partner, Bio + Health (promoted from Investing Analyst)
Apr 2022 — Present
Focuses on biotechnology investments.
Zak Doric invests in biotechnology companies as an investing partner on Andreessen Horowitz’s Bio + Health team. He previously developed biotech venture hypotheses at Flagship Pioneering and researched molecular mechanisms behind familial Parkinson’s disease while earning his UCSF neuroscience PhD.
Zak Doric invests in biotechnology companies as an investing partner on Andreessen Horowitz’s Bio + Health team. He previously developed biotech venture hypotheses at Flagship Pioneering and researched molecular mechanisms behind familial Parkinson’s disease while earning his UCSF neuroscience PhD.
Career
Gladstone Institutes / UCSFGraduate Researcher
Sep 2016 — Mar 2022
Studied molecular mechanisms responsible for familial forms of Parkinson's disease as a UCSF Hillblom Graduate Fellow.
Flagship PioneeringFellow
Jun 2021 — Aug 2021
Created venture hypotheses for new biotechnology company-creation efforts.
Bain & CompanyADvantage Intern
May 2021 — May 2021
Cosigns Received
Featured Media
a16z.com
Investing in Phylo
With Jorge Conde, argues for an integrated biology environment built around an AI scientist that coordinates tools, data, and models across research workflows.
a16z.com
Building AI Foundation Models for Molecular Design
A discussion of AI foundation models for molecular design and their role in drug discovery.
a16z.com
AI Jobs to be Done in Life Sciences
With Becky Pferdehirt, Bryan Faust, and Vijay Pande, a practical map of AI opportunities across life-sciences workflows.